论文信息 - Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma - 字舞流文

Modulation of Plasma Metabolite Biomarkers of the MAPK Pathway with MEK Inhibitor RO4987655: Pharmacodynamic and Predictive Potential in Metastatic Melanoma

M. Venturi | D. Skene | P. Workman | U. Banerji | S. Kaye | M. Valenti | A. K. de Haven Brandon | Alan T. Henley | F. Raynaud | S. Eccles | R. Rueger | G. Box | J. D. de Bono | V. Revell | J. Ang | Yasmin Asad | V. Méresse | A. Pál | V. Méresse